Sole Source: Illumina Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits
Overview
Buyer
Place of Performance
NAICS
PSC
Set Aside
Original Source
Timeline
Qualification Details
Fit reasons
- NAICS alignment with historical contract wins in similar service areas.
- Scope strongly matches core technical capabilities and delivery model.
Risks
- Past performance thresholds may require one additional teaming partner.
- Potential clarification needed on staffing minimums before bid/no-bid.
Next steps
Validate eligibility requirements, assign capture owner, and schedule partner outreach to confirm teaming strategy before submission planning.
Quick Summary
The Defense Health Agency Contracting Activity (DHACA), Healthcare Contracting Division – West (HCD-W), has issued a Notice of Intent to Award a Sole Source Supply Contract (HT941026N0054) to Illumina, Inc. This procurement is for Urinary Pathogen Identification (ID)/Antimicrobial Resistance (AMR) Enrichment Kits (UPIP) and Respiratory kits for the Department of Clinical Investigation (DCI) at Tripler Army Medical Center, Hawaii. This notice is not a request for competitive quotes.
Scope of Work
The requirement is for specific Illumina sequencing supplies, including:
- Illumina Urinary Pathogen Identification (ID)/AMR Enrichment Kit (UPIP)
- Respiratory Pathogen ID/AMR Enrichment Kit Set A and Set B
- PhiX Control v3
- NextSeq™1000/2000 P1 XLEAP-SBS Reagents
- MiSeq i100 Plus 50M Reagent Kit
- Illumina DNA Prep, Tagmentation
- Illumina DNA/RNA UD Indexes Set B
- NextSeq 1000/2000 P2 XLEAP-SBS Reagents
- Illumina Respiratory Virus Enrichment Kit Set A, Set B, Set D, and Set C
- Respiratory Virus Oligos Panel V2
- MiSeq i100 Plus 100M Reagent Kit
- MiSeq i100 25M Reagent Kit
- Illumina DNA/RNA UD Indexes Set C and Set D
These supplies are proprietary and specific for the Government-owned MiSeq Systems at Tripler Army Medical Center.
Contract & Timeline
- Type: Firm Fixed-Price Purchase Order (Sole Source)
- NAICS: 541714 (Research and Technology in Biotechnology); Size Standard: 1,000 employees
- PSC: 6550 (In Vitro Diagnostic Substances, Reagents, Test Kits And Sets)
- Set-Aside: Not Applicable (Sole Source Justification)
- Delivery Date: September 1, 2026
- Delivery Location: Tripler Army Medical Center, Department of Clinical Investigation, HI
- Published: May 4, 2026
Submission & Evaluation
This is a notice of intent, not a request for competitive proposals. Sources interested in challenging the sole source basis must submit a capability statement demonstrating their ability to provide the required equipment and preventive maintenance.
- Content: Management and technical data, and cost information.
- Format: Max six (8.5 x 11 inch) pages, 10-point font minimum.
- Submission Method: Email as a Microsoft Word or Adobe PDF attachment to Bobbie Dobberstein (bobbie.s.dobberstein.ctr@health.mil).
- Challenge Due: May 7, 2026, at 1000 Pacific Daylight Time.
- Note: No telephone requests or offers will be honored. Information received will be considered solely for the purpose of determining whether to conduct a competitive procurement or proceed with a sole source purchase order.
Justification
The Government justifies this sole source award to Illumina, Inc. because they are the only vendor manufacturing the specific sequencing supplies compatible with the DCI's Government-owned MiSeq Systems. There is no reasonable expectation of receiving quotes from two or more small businesses for these proprietary items.